Drugnews|藥時事

Orient EuroPharma Co., Ltd.

友華生技醫藥股份有限公司

4120 · TPEx-listed

Orient EuroPharma Co., Ltd. is a Taiwan TPEx-listed biotechnology company, as of 2026-11-01.

Pipeline

AssetTarget / mechanismStageIndicationRegionSource dateSource
未公開代號(嚴重痤瘡口服藥)—Preparing marketing authorization application documentsSevere acne—2026-03-31Company disclosure
未公開代號(癲癇口服藥)—Scale-up trial productionEpilepsy—2026-03-31Company disclosure
未公開代號(肢端肥大症針劑)—Formulation and process developmentAcromegaly—2026-03-31Company disclosure

Key events

No verified events in the past twelve months.

Related Drugnews articles